RAPT Therapeutics, Inc.RAPTEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 15.00% | 5.2M | ▲ +3.83pp | 2024-11-12 |
| Redmile Group, LLC | 9.90% | 3.8M | — | 2024-02-14 |
| The Vanguard Group | 9.04% | 3.2M | flat | 2024-11-12 |
| BlackRock, Inc. | 7.10% | 2.5M | — | 2024-01-26 |
| Perceptive Advisors LLC | 6.20% | 2.1M | — | 2024-02-14 |
| STATE STREET CORPORATION | 4.23% | 75.4K | — | 2024-01-23 |
| T. ROWE PRICE ASSOCIATES, INC. | 0.50% | 175.8K | ▼ -9.40pp | 2024-11-14 |
| Deep Track Capital, LP | 0.00% | 75.4K | ▼ -5.22pp | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-03 | Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | Disposed (U) | 4.6K | — | — |
| 2026-03-03 | GRAY MARY ANN | Director | Disposed (U) | 5.0K | — | — |
| 2026-03-03 | Giordano Michael F | Director | Disposed (U) | 5.0K | — | — |
| 2026-03-03 | Dombkowski Ashley L. | Director | Disposed (U) | 5.0K | — | — |
| 2026-03-03 | Lyons-Williams Lori | Director | Disposed (U) | 5.0K | — | — |
| 2026-03-03 | Young Rodney KB | CHIEF FINANCIAL OFFICER | Disposed (U) | 3.3K | — | — |
| 2026-03-03 | Wong Brian Russell | PRESIDENT AND CEO | Disposed (U) | 64.1K | — | — |
| 2026-03-03 | Linda Kozick | Director | Disposed (U) | 5.0K | — | — |
| 2026-03-03 | Scott Braunstein | Director | Disposed (U) | 5.0K | — | — |
1–9 of 9